Meanwhile, the decrease in IL-1β did not reach statistical significance ( Figure 8 G ).
← all excerpts
Ruxolitinib improves the inflammatory microenvironment, restores glutamate homeostasis, and promotes functional recovery after spinal cord injury.
1
—
—